Phthalic Acid

Phthalic Acid

SCHEMBL6322396

NC(=O)OC(=O)[C@@H]1CCCN1.O=C(O)c1ccccc1C(=O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.44
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 2/20 0.39
ALOX15 P16050 1/20 0.39
DPP4 P27487 2/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39
DPP8 Q6V1X1 1/20 0.39
ANPEP P15144 1/20 0.38
CTSC P53634 1/20 0.38
SCN4A P35499 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
NOS2 P35228 2/20 0.37
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
PARP1 P09874 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL5424564 1.00 ELANE (0.44) ELANECYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL564351 0.83 NOS2 (0.50) ELANECYP2D6DPP4DPP8NOS2
SCHEMBL7840173 0.83 NOS2 (0.50) ELANECYP2D6DPP4DPP8NOS2
SCHEMBL28789391 0.77 ELANE (0.48) ELANECYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL383987 0.77 ELANE (0.48) ELANECYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL21385077 0.75 ELANE (0.47) ELANECYP3A4CYP2D6CYP1A2CYP2C19
Phthalic Acid SCHEMBL5408646 0.75 CPB1 (0.41) ALDH1A1DPP4DPP8ANPEPTSHR
SCHEMBL9807318 0.74 ELANE (0.46) ELANECYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL15155167 0.74 ELANE (0.46) ELANECYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL30052597 0.74 NOS2 (0.42) ELANEDPP4DPP8SCN4ANOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050020677-A1 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use ORION CORPORATION (FI) 2005-01-27 US disclosed
EP-1401810-A1 COMPOUNDS HAVING PROLYL OLIGOPEPTIDASE INHIBITORY ACTIVITY, METHODS FOR THEIR PREPARATION AND THEIR USE ORION CORPORATION (FI) 2004-03-31 EP disclosed
WO-2003004468-A1 COMPOUNDS HAVING PROLYL OLIGOPEPTIDASE INHIBITORY ACTIVITY, METHODS FOR THEIR PREPARATION AND THEIR USE ORION CORPORATION (FI) 2003-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020677-A1 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use DNPEP, PREP, ANPEP ELANE 321/4885CYP3A4 2068/4885CYP2D6 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.